ACLY antibody (pSer455)
Quick Overview for ACLY antibody (pSer455) (ABIN6136002)
Target
See all ACLY AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- pSer455
-
Sequence
- TASFS
-
Cross-Reactivity
- Mouse, Rat
-
Characteristics
- Phosphorylated Antibodies
-
Purification
- Affinity purification
-
Immunogen
- A synthetic phosphorylated peptide around S455 of human ACLY (NP_001087.2).
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB,1:500 - 1:2000,IHC,1:50 - 1:100,IP,1:50 - 1:100
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- ACLY (ATP Citrate Lyase (ACLY))
-
Alternative Name
- ACLY
-
Background
- ATP citrate lyase is the primary enzyme responsible for the synthesis of cytosolic acetyl-CoA in many tissues. The enzyme is a tetramer (relative molecular weight approximately 440,000) of apparently identical subunits. It catalyzes the formation of acetyl-CoA and oxaloacetate from citrate and CoA with a concomitant hydrolysis of ATP to ADP and phosphate. The product, acetyl-CoA, serves several important biosynthetic pathways, including lipogenesis and cholesterogenesis. In nervous tissue, ATP citrate-lyase may be involved in the biosynthesis of acetylcholine. Multiple transcript variants encoding distinct isoforms have been identified for this gene.,ACLY,ACL,ATPCL,CLATP,Cancer,Signal Transduction,Endocrine & Metabolism,Lipid Metabolism,Insulin Receptor Signaling Pathway,Warburg Effect,Protein phosphorylation,ACLY
-
Molecular Weight
- 91 kDa/119 kDa/120 kDa
-
Gene ID
- 47
-
UniProt
- P53396
-
Pathways
- Warburg Effect
Target
-